Cyclopeptide Histone Deacetylase Inhibitors

被引:0
作者
Li Xiaohui [1 ]
Huang Meiling [1 ]
Liu Lina [1 ]
Wang Yanyun [1 ]
机构
[1] Dalian Univ Technol, Sch Life Sci & Biotechnol, Dalian 116024, Peoples R China
关键词
histone deacetylase; histone deacetylase inhibitor; cyclic peptides; anti-tumor; HELMINTHOSPORIUM-CARBONUM (HC)-TOXIN; CHROMOBACTERIUM-VIOLACEUM NO-968; CYCLIC TETRAPEPTIDE; HDAC INHIBITOR; BIOLOGICAL EVALUATION; CELL-DEATH; SPIRUCHOSTATIN-A; TRICHOSTATIN-A; DEPSIPEPTIDE; CANCER;
D O I
10.7536/PC140313
中图分类号
O6 [化学];
学科分类号
0703 ;
摘要
Histone deacetylase inhibitor is a novel class of histone deacetylase targeted anti-cancer drug, which takes excellent effects on anti-proliferation, pro-apoptosis, pro-differentiation, cell cycle arrest, anti-angiogenesis and so on. Histone deacetylase inhibitor plays an important role in the development of anticancer drug with its unique anti-tumor mechanism. Among the histone deacetylase inhibitors, the cyclopeptide histone deacetylase inhibitor with the most complicated structure has good antagonism on various types of solid tumors and hematologic cancer. In this review, the structural features of the metal binding region, the surface recognition region and the linker region of natural and synthetic cyclic peptide histone deacetylase inhibitors are summarized, and the inhibitory activity and anti-tumor proliferative activity of various inhibitors are described. Modification of different structure domains can make inhibitors with high efficiency and specificity on different tumor cells. We expect to find the structure rule of the high efficient and low toxic targeted peptide inhibitors through structure-activity relationships, providing new sights for investigation of anti-cancer drugs.
引用
收藏
页码:1527 / 1536
页数:10
相关论文
共 87 条
[1]   Histone deacetylase inhibitors: A new perspective for the treatment of leukemia [J].
Abujamra, Ana Lucia ;
dos Santos, Michel Pinheiro ;
Roesler, Rafael ;
Schwartsmann, Gilberto ;
Brunetto, Algemir Lunardi .
LEUKEMIA RESEARCH, 2010, 34 (06) :687-695
[2]   Histone deacetylase inhibitor, apicidin, inhibits human ovarian cancer cell migration via class II histone deacetylase 4 silencing [J].
Ahn, Mee Young ;
Kang, Dong O. ;
Na, Yong Jin ;
Yoon, Sungpil ;
Choi, Whan Soo ;
Kang, Keun Wook ;
Chung, Hae Young ;
Jung, Jee H. ;
Min, Do Sik ;
Kim, Hyung Sik .
CANCER LETTERS, 2012, 325 (02) :189-199
[3]   Apicidin, a histone deaceylase inhibitor, induces both apoptosis and autophagy in human oral squamous carcinoma cells [J].
Ahn, Mee-Young ;
Ahn, Sang-Gun ;
Yoon, Jung-Hoon .
ORAL ONCOLOGY, 2011, 47 (11) :1032-1038
[4]   Cyclic tetrapeptides with -SS- bridging between amino acid side chains for potent histone deacetylases' inhibition [J].
Arai, Toru ;
Hoque, Md Ashraful ;
Nishino, Norikazu ;
Kim, Hyun-Jung ;
Ito, Akihiro ;
Yoshida, Minoru .
AMINO ACIDS, 2013, 45 (04) :835-843
[5]   Chlamydocin analogs bearing carbonyl group as possible ligand toward zinc atom in histone deacetylases [J].
Bhuiyan, MPI ;
Kato, T ;
Okauchi, T ;
Nishino, N ;
Maeda, S ;
Nishino, TG ;
Yoshida, M .
BIOORGANIC & MEDICINAL CHEMISTRY, 2006, 14 (10) :3438-3446
[6]   Total synthesis and biological mode of action of largazole: A potent Class I histone deacetylase inhibitor [J].
Bowers, Albert ;
West, Nathan ;
Taunton, Jack ;
Schreiber, Stuart L. ;
Bradner, James E. ;
Williams, Robert M. .
JOURNAL OF THE AMERICAN CHEMICAL SOCIETY, 2008, 130 (33) :11219-11222
[7]   Synthesis and Histone Deacetylase Inhibitory Activity of Largazole Analogs: Alteration of the Zinc-Binding Domain and Macrocyclic Scaffold [J].
Bowers, Albert A. ;
West, Nathan ;
Newkirk, Tenaya L. ;
Troutman-Youngman, Annie E. ;
Schreiber, Stuart L. ;
Wiest, Olaf ;
Bradner, James E. ;
Williams, Robert M. .
ORGANIC LETTERS, 2009, 11 (06) :1301-1304
[8]   Histone deacetylase inhibitors: Mechanisms of cell death and promise in combination cancer therapy [J].
Carew, Jennifer S. ;
Giles, Francis J. ;
Nawrocki, Steffan T. .
CANCER LETTERS, 2008, 269 (01) :7-17
[9]   ISOLATION AND STRUCTURAL ELUCIDATION OF CHLAMYDOCIN [J].
CLOSSE, A ;
HUGUENIN, R .
HELVETICA CHIMICA ACTA, 1974, 57 (03) :533-545
[10]  
Cortez C C, 2005, EUROPEAN J MED CHEM, V40, P1